135 related articles for article (PubMed ID: 26919034)
1. Foxa1 is essential for mammary duct formation.
Liu Y; Zhao Y; Skerry B; Wang X; Colin-Cassin C; Radisky DC; Kaestner KH; Li Z
Genesis; 2016 May; 54(5):277-85. PubMed ID: 26919034
[TBL] [Abstract][Full Text] [Related]
2. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.
Feng Y; Manka D; Wagner KU; Khan SA
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14718-23. PubMed ID: 17785410
[TBL] [Abstract][Full Text] [Related]
4. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.
van Bragt MP; Hu X; Xie Y; Li Z
Elife; 2014 Nov; 3():e03881. PubMed ID: 25415051
[TBL] [Abstract][Full Text] [Related]
5. Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.
Best SA; Hutt KJ; Fu NY; Vaillant F; Liew SH; Hartley L; Scott CL; Lindeman GJ; Visvader JE
Development; 2014 Aug; 141(16):3159-64. PubMed ID: 25038044
[TBL] [Abstract][Full Text] [Related]
6. FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis.
Bernardo GM; Lozada KL; Miedler JD; Harburg G; Hewitt SC; Mosley JD; Godwin AK; Korach KS; Visvader JE; Kaestner KH; Abdul-Karim FW; Montano MM; Keri RA
Development; 2010 Jun; 137(12):2045-54. PubMed ID: 20501593
[TBL] [Abstract][Full Text] [Related]
7. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
Cornelissen LM; Henneman L; Drenth AP; Schut E; de Bruijn R; Klarenbeek S; Zwart W; Jonkers J
J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):305-321. PubMed ID: 31729597
[TBL] [Abstract][Full Text] [Related]
8. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
Yee CH; Zheng Z; Shuman L; Yamashita H; Warrick JI; Wu XR; Raman JD; DeGraff DJ
Sci Rep; 2019 Jan; 9(1):270. PubMed ID: 30670749
[TBL] [Abstract][Full Text] [Related]
10. FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.
DeGraff DJ; Grabowska MM; Case TC; Yu X; Herrick MK; Hayward WJ; Strand DW; Cates JM; Hayward SW; Gao N; Walter MA; Buttyan R; Yi Y; Kaestner KH; Matusik RJ
Lab Invest; 2014 Jul; 94(7):726-39. PubMed ID: 24840332
[TBL] [Abstract][Full Text] [Related]
11. Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland.
Xiang D; Tao L; Li Z
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31233030
[TBL] [Abstract][Full Text] [Related]
12. Deaf-1 regulates epithelial cell proliferation and side-branching in the mammary gland.
Barker HE; Smyth GK; Wettenhall J; Ward TA; Bath ML; Lindeman GJ; Visvader JE
BMC Dev Biol; 2008 Oct; 8():94. PubMed ID: 18826651
[TBL] [Abstract][Full Text] [Related]
13. Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.
McCune K; Mehta R; Thorat MA; Badve S; Nakshatri H
Oncol Rep; 2010 Nov; 24(5):1233-9. PubMed ID: 20878115
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
15. Conditional Wwox deletion in mouse mammary gland by means of two Cre recombinase approaches.
Ferguson BW; Gao X; Kil H; Lee J; Benavides F; Abba MC; Aldaz CM
PLoS One; 2012; 7(5):e36618. PubMed ID: 22574198
[TBL] [Abstract][Full Text] [Related]
16. Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation.
Booth BW; Boulanger CA; Smith GH
J Cell Physiol; 2007 Sep; 212(3):729-36. PubMed ID: 17443685
[TBL] [Abstract][Full Text] [Related]
17. Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland.
Onoyama I; Nakayama S; Shimizu H; Nakayama KI
Cancer Res; 2020 Dec; 80(24):5515-5530. PubMed ID: 33234509
[TBL] [Abstract][Full Text] [Related]
18. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
[TBL] [Abstract][Full Text] [Related]
20. RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini.
Gonzalez-Suarez E; Branstetter D; Armstrong A; Dinh H; Blumberg H; Dougall WC
Mol Cell Biol; 2007 Feb; 27(4):1442-54. PubMed ID: 17145767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
